GRIN2A and melanoma: In addition, the overexpression of the mutant GRIN2A in 31T and SK-Mel-2 melanoma cell lines increased the migration compared to both wild-type GRIN2A, whereas the use of a specific NMDAR2A (GRIN2A) antagonist, TCN-213 reversed the effect mentioned.